BPC-157: A Research Overview of the Synthetic Pentadecapeptide

BPC-157 is one of the most frequently searched synthetic peptides in the research community. This overview summarizes what the compound is, the pre-clinical contexts in which it has been studied, and how it is handled in a laboratory setting. All information here is framed for research use only.

What BPC-157 Is

BPC-157 is a synthetic pentadecapeptide — a chain of 15 amino acids — derived from a sequence found in a gastric protein. It is supplied as a lyophilized powder in a sealed research vial for use in controlled laboratory environments.

Class: Synthetic peptide (research material)
Structure: 15-amino-acid sequence
Appearance: Lyophilized (freeze-dried) powder
Documentation: Current Certificate of Analysis on file (HPLC ≥98% purity, mass-spec identity)

Research Background (Pre-Clinical)

BPC-157 has been the subject of an extensive body of pre-clinical investigation, the majority of it conducted in rodent models and in vitro systems. Much of the foundational laboratory work has been published by Sikirić and colleagues over several decades.

Published pre-clinical studies have examined BPC-157 in the context of:

Gastrointestinal research models — its origin as a gastric peptide derivative has made it a subject of digestive-system laboratory research
Musculoskeletal research models — including tendon, ligament, and muscle laboratory studies
Angiogenesis-related research — laboratory examination of blood-vessel-formation signaling
Cytoprotection research — cellular-resilience laboratory endpoints

Important framing: Every finding referenced above is from pre-clinical (animal or in vitro) research only. These laboratory observations have not been established in humans, and nothing here should be read as describing an effect in people. The compound is a research material, not a therapeutic.

Mechanism in the Research Literature

In pre-clinical models, BPC-157 has been associated in the published literature with signaling related to the nitric-oxide system and with angiogenic pathways (including VEGFR2-related signaling in laboratory studies). These are mechanistic observations reported in animal and in vitro research — they describe pathways researchers have examined, not established outcomes.

Analytical & Handling Notes

Storage (lyophilized): −20°C, protected from light and moisture
Stability: Lyophilized form is supplied for transit stability; refer to the current COA on file and storage guidance
Verification: Every vial carries a QR code linking to its batch Certificate of Analysis (HPLC purity)
Format: Single-component synthetic peptide, tamper-evident sealed vial

Important Notice

For Research Use Only (RUO). Not for human consumption. Not for human or veterinary use. Not intended to diagnose, treat, cure, or prevent any disease. This material is supplied solely for controlled laboratory research by qualified researchers.

References

Titles below are paraphrased to research-focus descriptions rather than quoted verbatim — each links to the original indexed publication for exact wording.

Petrovic I., et al. — gastrointestinal fistula rat model, nitric-oxide system, J Physiol Pharmacol., 2008. PMID 18818478
Krivic A., et al. — gastric mucosa rat model, cytoprotection research, Dig Dis Sci., 2004. PMID 15052688
Cerovecki T., et al. — ligament rat model, musculoskeletal research, J Orthop Res., 2010;28:1155–1161. PMID 20225319
Chang C.H., et al. — tendon cell outgrowth, survival, and migration, in vitro/rat model, J Appl Physiol., 2011. PMID 21030672
Hsieh M.J., et al. — VEGFR2 activation and angiogenesis signaling, in vitro/rat model, J Mol Med., 2017;95:323–333. PMID 27847966

All studies above are rodent (in vivo) or in vitro pre-clinical research. None involve human subjects. Cited for research-literature context only — not evidence of safety or efficacy in humans.

BPC-157 (10mg) is available as a research material in our catalog: view BPC-157 (10mg). All products are supplied for research use only.